Trademark: 90632071
Status Date
Thursday, June 16, 2022
Filing Date
Thursday, April 8, 2021
Abandoned Date
Saturday, June 4, 2022
5 Enabling specific activation and proliferation of tumor reactive T cells in isolated T cells from tumors and peripheral blood mononuclear cells. Providing effective cell therapy products for cancer immunotherapy
Jun 16, 2022
Abandonment Notice E-Mailed - Failure To Respond
Jun 16, 2022
Abandonment - Failure To Respond Or Late Response
Dec 3, 2021
Notification Of Non-Final Action E-Mailed
Dec 3, 2021
Non-Final Action E-Mailed
Dec 3, 2021
Non-Final Action Written
Nov 28, 2021
Assigned To Examiner
Jul 16, 2021
New Application Office Supplied Data Entered In Tram
Apr 12, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24